Tuesday, February 25

Finance

In what could represent a significant transformation of the insulin marketplace, Eli Lilly has announced it will slash the price of two of its insulin products by 70%; Humalog (insulin lispro) and Humulin (human insulin). Additionally, the company plans to greatly expand an existing patient assistance program by capping commercially insured and uninsured patients’ out-of-pocket costs at $35 a month.

In this article I cover a classic strategy that combines three fundamental factors into a score used to identify promising value stocks. The AAII Fundamental Rule of Thumb screen combines the price-earnings (P/E) ratio, dividend yield and adjusted return on equity (ROE). A list of stocks that currently pass the Fundamental Rule of Thumb screen is included below. This screening model has shown impressive long-term performance, with an average annual gain since 1998 of 9.6% through the close on February 28, 2023, versus 5.6% for the S&P 500 index over the same period. Read on to understand why this screen is still valid in today’s market.

From Alaska to Florida, America’s state and local governments have long been pushing their workers out of pensions into 401(k)-type retirement plans in response to looming budget deficits—misleadingly claiming the retirement benefits are comparable. Nearly two decades later, state workers have awakened to discover they were hoodwinked by their employers and retained financial advisors. Warnings that 401(k)-style plans provide significantly smaller benefits than pensions should have been heeded.

© 2025 The Money Times. All rights reserved